Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore

被引：0
|
作者：
Chay, J. [1 ]
Su, R. [1 ]
Tung, J. Y. M. [2 ]
Aslim, E. J. [2 ]
Wong, C. [3 ]
Swan, G.
Chua, W. J. [4 ]
Ho, S. S. H. [2 ]
Finkelstein, E. A. [1 ]
机构：
[1] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore
[2] Singapore Gen Hosp, Dept Urol, Singapore, Singapore
[3] Boston Sci, Asia Pacific, Hlth Econ & Market Access, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Dept Urol, Singapore, Singapore
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0034
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [41] Re: Cost-Effectiveness of Pembrolizumab in Second-Line Advanced Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2019, 202 (06): : 1095 - 1096
  • [42] Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer
    Nguyen, Trang T. H.
    Mital, Shweta
    PHARMACOECONOMICS, 2025, 43 (03) : 351 - 361
  • [43] First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review
    Zhang, Lan
    Sun, Junhui
    Wang, Kui
    Zhao, Haitao
    Zhang, Xijie
    Ren, Zhenggang
    CURRENT ONCOLOGY, 2022, 29 (10) : 7305 - 7326
  • [44] Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system
    Anezaki, Hisataka
    Endo, Fumiyasu
    Swan, Georgia
    Takashima, Kenta
    Rojanasarot, Sirikan
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 554 - 565
  • [45] Cost-effectiveness analysis of trastuzumab emtansine for second-line treatment of HER2+advanced breast cancer in Singapore
    Wong, Wei Han Melvin
    Ng, Raymond
    Aziz, Mohamed Ismail Abdul
    Ong, Benjamin Shao-Kiat
    Ng, Kwong
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [46] Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system
    Bahia, Luciana Ribeiro
    Araujo, Denizar Vianna
    Pepe, Camila
    Trindade, Michelle
    Camargo, Caroline Mendonca
    Javaroni, Valter
    INTERNATIONAL BRAZ J UROL, 2012, 38 (05): : 595 - 605
  • [47] COST-EFFECTIVENESS IN A VA COOPERATIVE STUDY OF PROSTATE SURGERY FOR BENIGN PROSTATIC HYPERPLASIA IN ELDERLY MEN
    KELLER, AM
    BERGER, DJ
    ZUBKOFF, M
    CONTROLLED CLINICAL TRIALS, 1987, 8 (03): : 292 - 293
  • [48] Re: Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2024, 212 (02): : 382 - 383
  • [49] Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma
    Pflugfelder, Annette
    Eigentler, Thomas K.
    Keim, Ulrike
    Weide, Benjamin
    Leiter, Ulrike
    Ikenberg, Kristian
    Berneburg, Mark
    Garbe, Claus
    PLOS ONE, 2011, 6 (02):
  • [50] Docetaxel in the first- and second-line therapy of gastric cancer
    Vanhoefer, U
    ONKOLOGIE, 2000, 23 : 40 - 42
12345